メインコンテンツに移動

XVAs boost Helaba trading income but inflate hedging costs

Expense from non-trading hedges reaches highest since at least 2016

Derivatives valuation adjustments (XVAs) cut both ways at German lender Helaba in the first half of the year, propelling trading income to the highest in at least six years while pushing hedging costs to their highest since the beginning of the Covid-19 pandemic.

Trading income hit €299 million ($299 million) in the six months to end-June – reversing a €28 million loss in H2 2021 and more than

コンテンツを印刷またはコピーできるのは、有料の購読契約を結んでいるユーザー、または法人購読契約の一員であるユーザーのみです。

これらのオプションやその他の購読特典を利用するには、info@risk.net にお問い合わせいただくか、こちらの購読オプションをご覧ください: http://subscriptions.risk.net/subscribe

現在、このコンテンツをコピーすることはできません。詳しくはinfo@risk.netまでお問い合わせください。

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

無料メンバーシップの内容をお知りになりたいですか?ここをクリック

パスワードを表示
パスワードを非表示にする

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

ログイン
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here